Servier and MiNA Target Neurodegenerative Disease With Novel RNA Therapy

$267m Deal Expands Biotech’s Research

 
• By Andrew McConaghie
  
Brain scan
After starting with liver diseases, MiNA will now look to target neurodegenerative diseases

More from Business

More from Scrip